Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22540492 | 0.91 | TSHR (0.35) | TSHRCYP2C9CA1CA2ALDH1A1 | |
| SCHEMBL22540502 | 0.91 | CYP2C9 (0.33) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL20171711 | 0.89 | TSHR (0.36) | TSHRCYP2C9CA1CA2CNR1 | |
| SCHEMBL19796641 | 0.89 | TSHR (0.36) | TSHRCYP2C9CA1CA2CNR1 | |
| SCHEMBL20171742 | 0.89 | TSHR (0.36) | TSHRCYP2C9CA1CA2CNR1 | |
| SCHEMBL20171766 | 0.89 | TSHR (0.36) | TSHRCYP2C9CA1CA2CNR1 | |
| SCHEMBL19722518 | 0.88 | CYP2C9 (0.37) | CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19796518 | 0.87 | TSHR (0.39) | TSHRCYP2C9CA1CA2ALDH1A1 | |
| SCHEMBL22083082 | 0.86 | TSHR (0.33) | TSHR | |
| SCHEMBL19796601 | 0.86 | TSHR (0.38) | TSHRCYP2C9CA1CA2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020116380-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC株式会社 | 2020-06-11 | — | — | WO | disclosed |